vs
Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and ServisFirst Bancshares, Inc. (SFBS). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $159.0M, roughly 1.0× ServisFirst Bancshares, Inc.). ServisFirst Bancshares, Inc. runs the higher net margin — 52.2% vs -82.0%, a 134.1% gap on every dollar of revenue. Over the past eight quarters, ServisFirst Bancshares, Inc.'s revenue compounded faster (17.7% CAGR vs -11.5%).
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
ServisFirst Bancshares, Inc. is a U.S.-based bank holding company operating full-service banking locations primarily across the Southeastern United States. It offers a full suite of commercial banking, consumer banking, wealth management, and mortgage lending services to small and medium-sized businesses, professional clients, and individual consumers.
PTCT vs SFBS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $164.7M | $159.0M |
| Net Profit | $-135.0M | $83.0M |
| Gross Margin | — | — |
| Operating Margin | -43.3% | — |
| Net Margin | -82.0% | 52.2% |
| Revenue YoY | -22.7% | — |
| Net Profit YoY | -104.8% | 31.2% |
| EPS (diluted) | $-1.63 | $1.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $159.0M | ||
| Q4 25 | $164.7M | $162.2M | ||
| Q3 25 | $211.0M | $136.3M | ||
| Q2 25 | $178.9M | $132.1M | ||
| Q1 25 | $1.2B | $131.8M | ||
| Q4 24 | $213.2M | $131.9M | ||
| Q3 24 | $196.8M | $123.7M | ||
| Q2 24 | $186.7M | $114.8M |
| Q1 26 | — | $83.0M | ||
| Q4 25 | $-135.0M | $86.4M | ||
| Q3 25 | $15.9M | $65.6M | ||
| Q2 25 | $-64.8M | $61.4M | ||
| Q1 25 | $866.6M | $63.2M | ||
| Q4 24 | $-65.9M | $65.2M | ||
| Q3 24 | $-106.7M | $59.9M | ||
| Q2 24 | $-99.2M | $52.1M |
| Q1 26 | — | — | ||
| Q4 25 | -43.3% | 66.3% | ||
| Q3 25 | 1.4% | 57.8% | ||
| Q2 25 | -19.5% | 58.0% | ||
| Q1 25 | 82.5% | 60.0% | ||
| Q4 24 | -76.2% | 60.2% | ||
| Q3 24 | -27.7% | 58.5% | ||
| Q2 24 | -21.5% | 58.0% |
| Q1 26 | — | 52.2% | ||
| Q4 25 | -82.0% | 59.0% | ||
| Q3 25 | 7.5% | 48.1% | ||
| Q2 25 | -36.3% | 46.5% | ||
| Q1 25 | 73.7% | 48.0% | ||
| Q4 24 | -30.9% | 52.9% | ||
| Q3 24 | -54.2% | 48.4% | ||
| Q2 24 | -53.1% | 45.4% |
| Q1 26 | — | $1.52 | ||
| Q4 25 | $-1.63 | $1.58 | ||
| Q3 25 | $0.20 | $1.20 | ||
| Q2 25 | $-0.83 | $1.12 | ||
| Q1 25 | $10.04 | $1.16 | ||
| Q4 24 | $-0.85 | $1.19 | ||
| Q3 24 | $-1.39 | $1.10 | ||
| Q2 24 | $-1.29 | $0.95 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9B | $1.8B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-205.3M | $1.9B |
| Total Assets | $2.9B | $18.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.8B | ||
| Q4 25 | $1.9B | — | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $2.0B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.0B | — | ||
| Q2 24 | $1.1B | — |
| Q1 26 | — | $1.9B | ||
| Q4 25 | $-205.3M | $1.8B | ||
| Q3 25 | $-155.8M | $1.8B | ||
| Q2 25 | $-206.5M | $1.7B | ||
| Q1 25 | $-185.8M | $1.7B | ||
| Q4 24 | $-1.1B | $1.6B | ||
| Q3 24 | $-1.1B | $1.6B | ||
| Q2 24 | $-980.2M | $1.5B |
| Q1 26 | — | $18.2B | ||
| Q4 25 | $2.9B | $17.7B | ||
| Q3 25 | $2.6B | $17.6B | ||
| Q2 25 | $2.6B | $17.4B | ||
| Q1 25 | $2.7B | $18.6B | ||
| Q4 24 | $1.7B | $17.4B | ||
| Q3 24 | $1.8B | $16.4B | ||
| Q2 24 | $1.9B | $16.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.3M | — |
| Free Cash FlowOCF − Capex | $-36.6M | — |
| FCF MarginFCF / Revenue | -22.3% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $702.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-34.3M | $355.2M | ||
| Q3 25 | $-66.3M | $140.9M | ||
| Q2 25 | $-58.3M | $67.6M | ||
| Q1 25 | $870.1M | $48.0M | ||
| Q4 24 | $-30.0M | $252.9M | ||
| Q3 24 | $-77.0M | $84.0M | ||
| Q2 24 | $-71.5M | $48.3M |
| Q1 26 | — | — | ||
| Q4 25 | $-36.6M | — | ||
| Q3 25 | $-69.7M | — | ||
| Q2 25 | $-59.6M | — | ||
| Q1 25 | $868.4M | — | ||
| Q4 24 | $-33.8M | — | ||
| Q3 24 | $-77.5M | — | ||
| Q2 24 | $-78.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | -22.3% | — | ||
| Q3 25 | -33.1% | — | ||
| Q2 25 | -33.3% | — | ||
| Q1 25 | 73.8% | — | ||
| Q4 24 | -15.8% | — | ||
| Q3 24 | -39.4% | — | ||
| Q2 24 | -42.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 1.8% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 4.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.11× | ||
| Q3 25 | -4.17× | 2.15× | ||
| Q2 25 | — | 1.10× | ||
| Q1 25 | 1.00× | 0.76× | ||
| Q4 24 | — | 3.88× | ||
| Q3 24 | — | 1.40× | ||
| Q2 24 | — | 0.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PTCT
Segment breakdown not available.
SFBS
| Net Interest Income | $148.1M | 93% |
| Noninterest Income | $10.8M | 7% |
